Anti-IDO1 antibody (50-150) [S2MR] (STJ11102742)

SPECIFICATIONS
ClonalityMonoclonal
HostRabbit
ConjugationUnconjugated
IsotypeIgG
STJ11102742
๐Ÿšš Free UK Delivery on orders over ยฃ150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionRabbit monoclonal IDO1 (50-150) antibody for use in IHC-P and ELISA in human and mouse samples. Datasheet included with dilution recommendations, and related reagents.
ApplicationsIHC-P/ELISA
HostRabbit
ReactivityHuman/Mouse
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ClonalityMonoclonal
Clone IDS2MR
IsotypeIgG
ConjugationUnconjugated
ConcentrationLot specific
PurificationAffinity purification
Dilution RangeIHC-P:1:50-1:200
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
FormulationPBS with 0.02% Sodium Azide, 0.05% BSA, 50% Glycerol, pH 7.3.
Storage InstructionStore at-20ยฐC for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.

Target Information

Gene SymbolIDO1
Gene ID3620
Uniprot IDI23O1_HUMAN
Immunogen Region50-150
Immunogen SequenceIESGQLRERVEKLNMLSIDH LTDHKSQRLARLVLGCITMA YVWGKGHGDVRKVLPRNIAV PYCQLSKKLELPPILVYADC VLANWKKKDPNKPLTYENMD V
SpecificityA synthetic peptide corresponding to a sequence within amino acids 50-150 of human IDO1 (P14902).

Additional Info

Tissue Specificity Expressed in mature dendritic cells located in lymphoid organs (including lymph nodes, spleen, tonsils, Peyers's patches, the gut lamina propria, and the thymic medulla), in some epithelial cells of the female genital tract, as well as in endothelial cells of term placenta and in lung parenchyma. Weakly or not expressed in most normal tissues, but mostly inducible in most tissues. Expressed in more than 50% of tumors, either by tumoral, stromal, or endothelial cells (expression in tumor is associated with a worse clinical outcome). Not overexpressed in tumor-draining lymph nodes.
Function Catalyzes the first and rate limiting step of the catabolism of the essential amino acid tryptophan along the kynurenine pathway. Involved in the peripheral immune tolerance, contributing to maintain homeostasis by preventing autoimmunity or immunopathology that would result from uncontrolled and overreacting immune responses. Tryptophan shortage inhibits T lymphocytes division and accumulation of tryptophan catabolites induces T-cell apoptosis and differentiation of regulatory T-cells. Acts as a suppressor of anti-tumor immunity. Limits the growth of intracellular pathogens by depriving tryptophan. Protects the fetus from maternal immune rejection.
Protein Name Indoleamine 2 -3-Dioxygenase 1
Ido-1
Indoleamine-Pyrrole 2 -3-Dioxygenase
Database Links Reactome: R-HSA-71240
Cellular Localisation Cytoplasm
Cytosol
Alternative Antibody Names Anti-Indoleamine 2 -3-Dioxygenase 1 antibody
Anti-Ido-1 antibody
Anti-Indoleamine-Pyrrole 2 -3-Dioxygenase antibody
Anti-IDO1 antibody
Anti-IDO antibody
Anti-INDO antibody

Information sourced from Uniprot.org

Citations

Product Review